Before the pandemic, the public perceived science as infallible and inaccessible. But the opening up of research to the general public has changed that perception.
A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
There is an urgent need to combat historically fuelled vaccine hesitancy within Indigenous communities. The best way to do this is through evidence-based knowledge and community-led work.
For the one in 10 people with a significant fear of needles, getting a vaccination is distressing. This can disrupt vaccination campaigns, but there are effective ways to manage pain and fear.
Sorana Froda, Université du Québec à Montréal (UQAM) e Fabrice Larribe, Université du Québec à Montréal (UQAM)
Vaccine efficacy is usually expressed as a percentage, but what is it actually measuring? Statisticians explain what the numbers mean, and what they say about how well a vaccine can protect us.
Vaccine hesitancy is declining in Canada but hasn’t disappeared. New research shows many of those initially less hesitant have since been convinced. With continued efforts, others can still be reached.
Exclusion from clinical trials, lack of data and inconsistent information made it difficult for pregnant and breastfeeding people to make decisions about COVID-19 vaccines early in the rollout.
Hotspot neighbourhoods with greater COVID-19 risk exposure continued to have higher infection rates even when they achieved vaccination levels equal to lower-risk neighbourhoods.
With youth ages 12 and over eligible for COVID-19 vaccination — and as trials for younger children move ahead — parental hesitancy is emerging as the new challenge for COVID-19 vaccine programs.
At the height of polio and H1N1, Canadians were keen to get vaccinated, but vaccine enthusiasm waned once the crisis had passed — what does that mean for COVID-19?
Gardening provides a helpful metaphor to help us understand how individual and platform approaches to misinformation need to be accompanied by policy and cultural reforms.
As vaccine eligibility is expanded to adolescents and young adults, understanding who might be more likely to be vaccine hesitant, and why, can help inform public health strategies
From maternity wards to primary care, Canadian researchers are looking to find the positive motivations of vaccine hesitant people, whether they are new parents or other adults.